최신 재무제표(Form-10K)에 따르면, Camtek Ltd의 총 자산은 $0이며, 순손실입니다.
PDRX의 주요 재무 비율은 무엇인가요?
Camtek Ltd의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
PD-RX Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Camtek Ltd 주요 수익원은 Inspection and Metrology Equipment이며, 최신 수익 발표에서 수익은 468,510,000입니다. 지역별로는 China이 Camtek Ltd의 주요 시장이며, 수익은 243,935,000입니다.
PD-RX Pharmaceuticals Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Camtek Ltd의 순손실은 $0입니다.
PD-RX Pharmaceuticals Inc에 부채가 있나요?
no, Camtek Ltd의 부채는 0입니다.
PD-RX Pharmaceuticals Inc의 발행 주식은 몇 주인가요?
Camtek Ltd의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$3.35
시가
$2.8
일일 범위
$2.8 - $3.35
52주 범위
$2.41 - $3.35
거래량
250
평균 거래량
1.3K
배당수익률
--
EPS(TTM)
--
시가총액
$5.1M
PDRX란 무엇인가요?
PD-Rx Pharmaceuticals, Inc. engages in the pharmaceutical services business. The company is headquartered in Oklahoma City, Oklahoma. The company went IPO on 2001-12-17. The firm has a complete line of pharmaceutical repackaging for physician dispensing as well as Web-based software to manage point-of-care dispensing. Its software solution tailored to physicians who want to add or enhance their medication dispensing capabilities. The Company’s services cater to multiple specialties, including primary care, urgent care, pain management, occupational medicine, orthopedic medicine, bariatric care, and dental practices. Its automated production line produces approximately 2,000 bottles per hour. The firm can develop private labels for repackaged pharmaceuticals and also duplicate the current design or create new artwork. The company has point of care programs for all types of orthopedic practices, such as outpatient surgery, outpatient care and workers compensation.